Tenaya Therapeutics, Inc. - TNYA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | — | S | D | 1,862,545.0 | 0.5624 | 1,047,495.31 | 0.0 | View | |
| Feb 26, 2026 | — | S | D | 1,649,281.0 | 0.5624 | 927,555.63 | 0.0 | View | |
| Feb 26, 2026 | — | S | D | 349,212.0 | 0.6153 | 214,870.14 | 1,862,545.0 | View | |
| Feb 26, 2026 | — | S | D | 309,228.0 | 0.6153 | 190,267.99 | 1,649,281.0 | View | |
| Feb 24, 2026 | — | S | D | 162,291.0 | 0.5972 | 96,920.19 | 2,211,757.0 | View | |
| Feb 24, 2026 | — | S | D | 143,709.0 | 0.5972 | 85,823.01 | 1,958,509.0 | View | |
| Feb 24, 2026 | — | S | D | 277,769.0 | 0.6149 | 170,800.16 | 2,374,048.0 | View | |
| Feb 24, 2026 | — | S | D | 245,965.0 | 0.6149 | 151,243.88 | 2,102,218.0 | View | |
| Feb 17, 2026 | Chief Executive Officer | S | D | 5,032.0 | 0.643 | 3,235.58 | 443,404.0 | View | |
| Feb 17, 2026 | Chief Executive Officer | S | D | 3,979.0 | 0.6431 | 2,558.89 | 448,436.0 | View | |
| Feb 17, 2026 | Chief Executive Officer | S | D | 5,851.0 | 0.643 | 3,762.19 | 452,415.0 | View | |
| Feb 17, 2026 | SVP, Finance | S | D | 2,022.0 | 0.6431 | 1,300.35 | 119,752.0 | View | |
| Feb 17, 2026 | SVP, Finance | S | D | 836.0 | 0.6434 | 537.88 | 121,774.0 | View | |
| Feb 17, 2026 | SVP, Finance | S | D | 611.0 | 0.6434 | 393.12 | 122,610.0 | View | |
| Feb 17, 2026 | Chief Medical Officer | S | D | 1,876.0 | 0.6431 | 1,206.46 | 218,618.0 | View | |
| Feb 17, 2026 | Chief Medical Officer | S | D | 1,642.0 | 0.6432 | 1,056.13 | 220,494.0 | View | |
| Feb 17, 2026 | Chief Medical Officer | S | D | 1,642.0 | 0.6432 | 1,056.13 | 222,136.0 | View | |
| Feb 12, 2026 | — | S | D | 2,151,458.0 | 0.6808 | 1,464,712.61 | 2,651,817.0 | View | |
| Feb 12, 2026 | — | S | D | 1,905,115.0 | 0.6808 | 1,297,002.29 | 2,348,183.0 | View | |
| Feb 12, 2026 | — | S | D | 182,295.0 | 0.8161 | 148,770.95 | 4,803,275.0 | View | |
| Feb 12, 2026 | — | S | D | 161,422.0 | 0.8161 | 131,736.49 | 4,253,298.0 | View | |
| Feb 05, 2026 | Chief Executive Officer | A | A | 952,250.0 | 0.0 | 0.0 | 952,250.0 | View | |
| Feb 05, 2026 | Chief Executive Officer | A | A | 158,600.0 | 0.0 | 0.0 | 458,266.0 | View | |
| Feb 05, 2026 | Chief Medical Officer | A | A | 318,500.0 | 0.0 | 0.0 | 318,500.0 | View | |
| Feb 05, 2026 | Chief Medical Officer | A | A | 48,750.0 | 0.0 | 0.0 | 223,778.0 | View | |
| Feb 05, 2026 | SVP, Finance | A | A | 175,500.0 | 0.0 | 0.0 | 175,500.0 | View | |
| Feb 05, 2026 | SVP, Finance | A | A | 29,250.0 | 0.0 | 0.0 | 123,221.0 | View | |
| Nov 17, 2025 | Chief Medical Officer | S | D | 2,877.0 | 1.33 | 3,826.41 | 169,926.0 | View | |
| Nov 17, 2025 | SVP, Finance | S | D | 1,367.0 | 1.33 | 1,818.11 | 93,971.0 | View | |
| Nov 17, 2025 | Chief Executive Officer | S | D | 3,126.0 | 1.33 | 4,157.58 | 299,666.0 | View |